PROCESSING OF URUSHIOL (POISON-IVY) HAPTEN BY BOTH ENDOGENOUS AND EXOGENOUS PATHWAYS FOR PRESENTATION TO T-CELLS IN-VITRO

被引:71
作者
KALISH, RS
WOOD, JA
LAPORTE, A
机构
[1] Department of Dermatology, State Univ. New York at Stony Brook, Stony Brook
[2] Department of Dermatology, Health Science Center T-16, State Univ. New York at Stony Brook, Stony Brook
关键词
ANTIGEN-PRESENTING CELLS; T LYMPHOCYTES; HAPTENS; DERMATITIS; ALLERGIC CONTACT;
D O I
10.1172/JCI117198
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The antigen processing requirements for urushiol, the immunogen of poison ivy (Toxicodendron radicans), were tested by presentation of urushiol to cultured human urushiol-responsive T cells. Urushiol was added to antigen-presenting cells (APC) either before or after fixation with paraformaldehyde. Three distinct routes of antigen processing were detected. CD8+ and CD4+ T cells, which were dependent upon processing, proliferated if urushiol was added to APC before fixation, but did not proliferate when urushiol was added to APC after fixation. Processing of urushiol for presentation to CD8+ T cells was inhibited by azide, monensin, and brefeldin A. This suggests that urushiol was processed by the endogenous pathway. In contrast, presentation of urushiol to CD4+ T cells was inhibited by monensin but not by brefeldin A. This was compatible with antigen processing by the endosomal (exogenous) pathway. Finally, certain CD8+ T cells recognized urushiol in the absence of processing. These cells proliferated in response to APC incubated with urushiol after fixation. Classification of contact allergens by antigen processing pathway may predict the relative roles of CD4+ and CD8+ cells in the immunopathogenesis of allergic contact dermatitis.
引用
收藏
页码:2039 / 2047
页数:9
相关论文
共 53 条
  • [1] INHIBITION BY BREFELDIN-A OF PRESENTATION OF EXOGENOUS PROTEIN ANTIGENS TO MHC CLASS-II-RESTRICTED T-CELLS
    ADORINI, L
    ULLRICH, SJ
    APPELLA, E
    FUCHS, S
    [J]. NATURE, 1990, 346 (6279) : 63 - 66
  • [2] HAM-2 CORRECTS THE CLASS-I ANTIGEN-PROCESSING DEFECT IN RMA-S CELLS
    ATTAYA, M
    JAMESON, S
    MARTINEZ, CK
    HERMEL, E
    ALDRICH, C
    FORMAN, J
    LINDAHL, KF
    BEVAN, MJ
    MONACO, JJ
    [J]. NATURE, 1992, 355 (6361) : 647 - 649
  • [3] Baer H, 1986, Clin Dermatol, V4, P152, DOI 10.1016/0738-081X(86)90074-X
  • [4] PROCESSING REQUIREMENTS FOR T-CELL ACTIVATION BY MYCOPLASMA-ARTHRITIDIS-DERIVED MITOGEN
    BAUER, A
    RUTENFRANZ, I
    KIRCHNER, H
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (12) : 2109 - 2112
  • [5] THE PROCESSING AND PRESENTATION OF MYCOBACTERIAL ANTIGENS BY HUMAN-MONOCYTES
    BHARDWAJ, V
    COLSTON, MJ
    [J]. EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (05) : 691 - 696
  • [6] COMPONENT ANALYSIS OF URUSHIOL CONTENT OF POISON IVY AND POISON OAK
    BILLETS, S
    CRAIG, JC
    CORBETT, MD
    VICKERY, JF
    [J]. PHYTOCHEMISTRY, 1976, 15 (04) : 533 - 535
  • [7] BOECKER C, 1993, J INVEST DERMATOL, V100, pA540
  • [8] ASSAY OF PROTEIN-QUINONE COUPLING INVOLVING COMPOUNDS STRUCTURALLY RELATED TO ACTIVE PRINCIPLE OF POISON IVY
    BYCK, JS
    DAWSON, CR
    [J]. ANALYTICAL BIOCHEMISTRY, 1968, 25 (1-3) : 123 - &
  • [9] INVITRO STUDIES OF POISON OAK IMMUNITY .1. INVITRO REACTION OF HUMAN-LYMPHOCYTES TO URUSHIOL
    BYERS, VS
    EPSTEIN, WL
    CASTAGNOLI, N
    BAER, H
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (05) : 1437 - 1448
  • [10] CLAESEN M, 1982, DRUG METAB DISPOS, V10, P667